Intel (INTC) Valuation: From Deep Value to a $200 Call

Why a $200 Call Is Moving Intel Now

Short answer: Intel is no longer a deep-value stock. At 51.4x forward earnings, it's the most expensive name in our semiconductor coverage, and the $200 bull case depends on foundry deals that aren't signed yet.

Intel closed Wednesday, September 16, up 4% after Melius Research analyst Ben Reitzes said the stock could double to $200 within two years, built on foundry agreements with Apple, Tesla, and "one other hyperscaler" for Intel's 14A node (CNBC, Sept. 16, 2026). The note landed alongside a Reuters report that Intel is discussing leasing part of its Ohio fab to SK Hynix for U.S.-based memory chip production (TechSpot, Sept. 16, 2026, citing Reuters). Intel called the reports speculation, and SK Hynix said it was reviewing several locations without naming a partner. SK Hynix is also at the center of the memory-capacity crunch that's reshaping Nvidia's own supply chain this year.

It's a bold call, and a lonely one. Of 50 analysts covering Intel, just 15 rate it buy or strong buy; 33 sit on hold (CNBC, citing LSEG data). That split is the real story. Intel has more than quadrupled since August 2025, but it has already given back about a third of those gains. It hit a $142.35 record high on June 30, fell into the $120s after a single-session 9% drop on July 2, sank to $92.32 the day after July earnings, and closed September 16 at $101.05 (Motley Fool, Jul. 24, 2026; Yahoo Finance). A $200 target and a mostly-Hold Street can't tell you on their own which parts of Reitzes' bull case reflect a genuine turnaround. That's the question here: how much of this is real recovery, and how much is a rescue-fueled rally that has outrun the fundamentals?

Key Takeaways

• Intel went from a $20.47 rescue price in August 2025 to a $142.35 record on June 30, 2026, then closed September 16 at $101.05: 29% below the peak, still nearly five times the rescue price.
• Melius's Ben Reitzes sees $200 within two years if 14A reaches volume production by 2028 with Apple, Tesla, and a hyperscaler signed. Only 15 of 50 analysts rate the stock a buy; 33 say hold (CNBC, Sept. 16, 2026).
• Q2 2026 revenue grew 25% to $16.1 billion, Intel's fastest growth since 2011, but outside customers supplied only about 5% of Foundry revenue (CNBC, Jul. 23, 2026).
• At 51.4x forward earnings, Intel is the most expensive of the 23 chip stocks we track, against a 24.5x peer median, while its expected 35% EPS growth ranks only tenth (SPXScore forward-data tracking, Sept. 17, 2026 snapshot, priced on the Sept. 16 close).
• The floor under the rally was outside capital: the U.S. government's 9.9% stake, $2 billion from SoftBank, and $5 billion from Nvidia (Intel Newsroom, Aug. 22, 2025).
• The backdrop just got harder: 10-year yields topped 5% and the Fed hiked to 3.75%–4% on September 16, its first increase in three years (CNBC).

Four Valuation Phases in Thirteen Months

The stock's chart doesn't tell one story. It tells four, each with a different driver. That kind of phase pattern has shown up elsewhere in the chip sector this year too, including at Micron.

Phase	Date	Price	What Was Driving It
1. Deep value / distress	Through Aug. 2025	Low-to-mid $20s	CEO turnover, foundry delays, no committed external 18A customer
2. Government-backed rescue rally	Aug.–Dec. 2025	$20.47 stake (Aug.); +22% day on Nvidia deal (Sept.)	U.S. stake, SoftBank, Nvidia investments restore solvency confidence
3. Peak optimism (record high)	Through Jun. 30, 2026	$142.35	Apple preliminary-deal report (May), 18A-P risk production (June); Q1 revenue growth only 7%
4. Pullback, then renewed optimism	Jul.–Sept. 2026	$127.02 → $92.32 → $101.05	Meta AI-capacity report, thin external foundry revenue in Q2, $20B share sale, Sept. chip selloff, then Melius's $200 call

A Government Rescue, Not an Organic Recovery

Intel's "deep value" phase wasn't a market misreading a healthy business. It was pricing in real risk. By mid-2025, CEO Pat Gelsinger was gone, the 18A node had no committed outside foundry customer, and shares sat in the low-to-mid $20s. What turned it around wasn't demand recovery; it was three checks.

On August 22, 2025, the Trump administration converted $5.7 billion in unpaid CHIPS Act grants and $3.2 billion from the Secure Enclave program into a 9.9% equity stake: 433.3 million shares at $20.47, making the U.S. government Intel's largest shareholder (Intel Newsroom, Aug. 22, 2025). SoftBank had committed $2 billion three days earlier (The Register, Aug. 19, 2025). Nvidia followed a month later with $5 billion. That sent Intel up 22% in one session, its best day in nearly four decades (CNBC, Sept. 18, 2025).

That matters for reading today's setup: the floor under Intel was political and strategic capital, not earnings. It's a real backstop: the stake is worth multiples of its cost, and it gives Intel a "domestic fab premium" offshore rivals lack as U.S. tariff policy hardens (related: domestic fab premium and semiconductor tariffs). But the 2025 low wasn't a bargain hiding in plain sight; it needed outside capital to stabilize.

Peak Optimism: Priced on Headlines Before the Numbers

The run to $142.35 was priced on deal news more than on reported results. In May, The Wall Street Journal reported that Apple and Intel had reached a preliminary agreement for Intel to make some Apple chips, and on June 16 Intel said its 18A-P node had entered risk production (Motley Fool, Jul. 2, 2026; CNBC, Jun. 16, 2026). The results public at the time were far more modest. Q1 2026 revenue grew about 7% to $13.58 billion, the quarter still ended in a $3.73 billion net loss, and Foundry revenue rose 16% to $5.4 billion, of which only $174 million came from outside customers (Yahoo Finance, Jul. 2, 2026; Motley Fool, Jul. 2, 2026). The peak priced in the arrival of outside foundry demand well before any quarter showed it.

The first crack came on July 2. A report that Meta Platforms might sell excess AI computing capacity raised doubts about how scarce AI compute would stay, chip stocks sold off, and Intel fell 9% to $127.02, then another 5% to $120.35 the next day (Motley Fool, Jul. 2, 2026). Yahoo Finance called it "the first real crack in the Lip-Bu Tan turnaround narrative" (Yahoo Finance, Jul. 2, 2026).

The Q2 report on July 23 then delivered the growth the peak had assumed. Revenue rose 25% year-over-year to $16.1 billion, Intel's fastest growth since 2011, with Data Center and AI revenue up 59% to $6.3 billion, both beating estimates (CNBC, Jul. 23, 2026). Foundry revenue climbed 31% to $5.8 billion, but external customers contributed only $293 million of it, about 5%, and Intel raised its 2026 capex plan to more than $20 billion (Investing.com, Jul. 23, 2026). The quarter confirmed the growth story and showed how thin outside foundry demand still was. Shares closed down 7.9% at $92.32 the next day as investors questioned foundry demand, the spending plan, and the risk of dilution (Motley Fool, Jul. 24, 2026).

The Pullback, and a Fresh Peak-Optimism Bid

The dilution risk arrived quickly. On August 10, Intel upsized a stock offering to $20 billion at $95 a share (CNBC, Aug. 10, 2026), selling stock into a partial recovery rather than waiting for a higher price.

In mid-September the stock was caught in a broader chip-sector selloff during the same seven-shock week that rattled retail investors across the market. On September 14–15, Intel and Micron dragged the Nasdaq lower while Caterpillar led the Dow down. The selloff coincided with public warnings from AI leaders including Sam Altman, Dario Amodei, and Elon Musk that AI development was outrunning safety guardrails, and AI-adjacent hardware names were among the hardest hit (TheStreet, Sept. 14, 2026). It was part of the broader AI-valuation bubble debate playing out across the sector.

That's the backdrop the Melius note and SK Hynix report landed into on September 16, not a quiet market, but one already jumpy about chip-sector risk. The 4% pop off the Reitzes call is real, and the stock tacked on another 7.7% the next day. But even at the September 17 close of $108.80, Intel sat about 24% below its own June high. That's a bounce, not a breakout to new territory. To keep the numbers comparable, the valuation math in this article uses the September 16 close of $101.05, the price our forward-earnings snapshot is built on.

The Bull Case vs. What the Street Actually Thinks

Reitzes' math is specific: if 14A reaches high-volume manufacturing by 2028 with Apple, Tesla, and a hyperscaler committed, he argues the foundry business alone is "worthy of a 4x multiple," adding roughly $100 to the stock; if server CPU pricing holds and AI PC mix keeps lifting average selling prices, another $100 comes from $4-plus product earnings. Add the two and Intel is $200 (CNBC, Sept. 16, 2026).

It's coherent, but it's a 2028 thesis applied to a 2026 stock, riding on customer commitments (Apple, Tesla, an unnamed hyperscaler, the SK Hynix lease) that are reported and preliminary, not signed. Annualizing Q2's $16.1 billion quarterly run-rate gives roughly $64 billion of revenue. With about 5.25 billion shares outstanding after the Nvidia and SoftBank investments and August's share sale (stockanalysis.com), the September 16 close puts Intel's market cap near $530 billion, or about 8x sales. That's our estimate rather than a company-reported multiple, and it already assumes much of this story plays out.

That's why Reitzes is an outlier. The 50-analyst consensus is 15 buy or strong buy, 33 hold, and the remainder sell: not bearish, but a Street waiting for proof rather than pricing in $200 (CNBC, Sept. 16, 2026). A separate 49-analyst panel shows the same shape (15 buy or strong buy, 32 hold, 2 sell) with an average target of $115.74, roughly 15% above the September 16 close, not a double (stockanalysis.com, Sept. 2026). Wall Street's base case is modest continued execution, not the 14A-plus-Apple-plus-Tesla scenario Melius is underwriting.

What the Forward Multiple Actually Says

Reitzes' $200 and the Street's $115.74 are both price targets, and price targets are opinions. The multiple underneath them is arithmetic, and it's where Intel looks least like a bargain.

Our September 17, 2026 snapshot is priced on the September 16 close of $101.05. At that price, Intel carried a forward P/E of 51.4x, which implies about $1.97 of forward earnings per share (adjusted, not GAAP). The 22 other semiconductor names Intel is benchmarked against had a median forward P/E of 24.5x (SPXScore forward-data tracking). Intel carries roughly 2.1 times its peer field's multiple on next year's earnings. And the premium didn't shrink the next day: Intel added another 7.7% on September 17 to close at $108.80 (Yahoo Finance), which works out to about 55x the same $1.97 estimate.

How the peer benchmark works: the peer group is every other company in our S&P 500 coverage tagged as semiconductors: ADI, AMAT, AMD, AVGO, FSLR, KLAC, LRCX, MCHP, MPWR, MRVL, MU, NVDA, NXPI, ON, Q, QCOM, SNDK, STX, SWKS, TER, TXN, and WDC. Forward P/E for every name here is Finnhub's published forward-P/E metric, carried through as-is rather than recomputed against the September 17 close; the per-share earnings figures quoted above are what that ratio implies at that day's price. Since this snapshot the site has changed method — it now divides the current price by next-fiscal-year consensus EPS from Yahoo Finance — so /sp500/intc shows a different multiple today. The benchmark is the median, with Intel left out so it isn't measured against a number it helped set. One caveat: the tag is broad. It mixes chip designers, equipment makers, analog suppliers, storage names (STX, WDC, SNDK), and even First Solar, and none of them is a foundry in the middle of a turnaround. Treat the median as a market-wide reference point, not a like-for-like comparison.

That gap says more than the sales multiple does. On a GAAP basis Intel is still losing money: $2.12 per share over the trailing twelve months, on a net margin of -19.8% (SPXScore forward-data tracking, Sept. 17, 2026 snapshot). The forward P/E only works because analysts measure adjusted earnings, which strip out restructuring and impairment charges. Analysts reach for a revenue multiple when earnings can't carry the valuation yet, and about 8x sales is doing exactly that job here.

The growth case is real, but it isn't exceptional, and that's the part the $200 call glides past. Consensus has Intel's adjusted earnings per share growing about 35% next fiscal year. Across the 23 semiconductor names we track, that ranks tenth, against a group median of 28% and a mean of 40% (SPXScore forward-data tracking). Middle of the pack.

Now put the two numbers together. Intel carries the highest forward multiple in the entire group, ahead of Monolithic Power at 47.5x and AMD at 43.8x, while AMD is expected to grow next-year earnings about 106% and Nvidia about 68% at 18.1x. Intel is the most expensive of the 23 chip stocks we track on forward earnings, and it's buying middling growth with that premium. Run it forward and the arithmetic gets no kinder: two more consecutive 35% years, with the price frozen the entire time, would bring Intel to roughly 28x, about where its peer group trades today. The multiple isn't pricing a recovery. It's pricing the recovery plus the foundry story Reitzes is underwriting.

One more number connects this section to the rate backdrop below. Intel's beta is about 2.4, among the four highest in the semiconductor group alongside SanDisk, AMD, and Micron, meaning the stock has historically moved more than twice as hard as the broad market in both directions (SPXScore forward-data tracking). A high-beta name trading at twice its peer multiple is precisely the profile a rising discount rate punishes first. You can compare how the same framework reads across the rest of the sector in our S&P 500 coverage.

Today's Macro Backdrop

This rally is unfolding against a mixed economy. August's jobs report beat sharply: 162,000 nonfarm payrolls against a roughly 53,000 consensus, with unemployment at 4.1% (BLS, Sept. 4, 2026). August CPI held headline inflation at 3.4% year-over-year, core at 2.4% (BLS, Sept. 11, 2026).

Together, these pushed the 10-year Treasury yield as high as 5.014% intraday, its highest since 2007 (CNBC, Sept. 14, 2026). The Fed responded on September 16 with its first hike in three years, a quarter point to 3.75%–4%, and Chair Kevin Warsh called inflation "too high ... for too long" (CNBC; Bloomberg, Sept. 16, 2026).

Higher-for-longer rates cut two ways: they raise the discount rate on Reitzes' 2028 scenario, and the cost of the more-than-$20-billion 2026 capex plan funding 14A capacity (CNBC, Jul. 23, 2026). Energy is a second pressure. Iran-linked attacks forced Saudi Arabia to shut its East-West pipeline, the Red Sea export route it had used to bypass Strait of Hormuz disruptions, and crude climbed back above $100 a barrel (Fortune, Sept. 12, 2026). Intel's direct exposure is limited, since fabs run mostly on electricity rather than crude. The bigger channel is inflation: $100 oil keeps pressure on the Fed and on long yields while Intel's capex bill peaks, and it added to the risk-off mood chip stocks sold into in mid-September.

Cutting the other way, the administration's escalating tariff posture toward trading partners, straining relations with Canada and other partners, continues to favor domestic capacity like Intel's Arizona and Ohio fabs over offshore-dependent rivals.

Conclusion: Is This a Real Opportunity?

There's a real bull case, and it isn't fabricated. The government, SoftBank, and Nvidia backstops are genuine and durable, revenue growth at 25% is genuine, and the Apple and SK Hynix conversations are genuine, if unconfirmed. But calling today's setup "deep value," the way $20.47 was, would be wrong. The stock has already re-rated nearly five-fold off that base, carries the highest forward multiple among the 23 chip stocks we track at 51.4x for tenth-ranked growth, rests on a foundry business earning only 5% of its revenue from outside customers, and its most bullish target depends on commitments that haven't been signed.

The $200 call is a specific, well-reasoned, outlier bet on 2028 execution, not a market failing to notice a bargain. A Street that's two-thirds Hold, with an average price target near $116, is the more honest read of where the evidence sits today. For investors with genuine multi-year conviction in the foundry turnaround, the SK Hynix and Apple confirmations are the events to watch; for anyone treating $200 as the base case rather than the ceiling, the evidence sits closer to the Street's Hold stance: the number that would change the picture is the external foundry revenue share, not the headlines.

---

This article discusses Intel's historical stock performance and macroeconomic conditions as of September 17, 2026, for informational purposes only. It is not investment advice or a recommendation to buy or sell any security. Financial data, analyst targets, and reported deal discussions referenced here, including the SK Hynix and Apple foundry talks, are preliminary or unconfirmed as of this writing and are subject to change.